Objective Orofacial manifestations are significantly impactful in patients with systemic sclerosis (SSc) yet remain understudied, with no dedicated clinical guidelines to inform their management. Methods An international online survey comprised38 questions addressing orofacial manifestations of SSc, including patients’ confidence in their treating ...
Eleni Deligianni +4 more
wiley +1 more source
Safety evaluation of the food enzyme glucan 1,4-α-glucosidase from the non-genetically modified <i>Aspergillus niger</i> strain AE-GN. [PDF]
EFSA Panel on Food Enzymes (FEZ) +20 more
europepmc +1 more source
Safety evaluation of an extension of use of a food enzyme containing bacillolysin and subtilisin activities from the non-genetically modified <i>Bacillus amyloliquefaciens</i> strain AR-383. [PDF]
EFSA Panel on Food Enzymes (FEZ) +15 more
europepmc +1 more source
Safety evaluation of an extension of use of the food enzyme cellulase from the genetically modified <i>Trichoderma reesei</i> strain AR-852. [PDF]
EFSA Panel on Food Enzymes (FEZ) +14 more
europepmc +1 more source
Evaluating the Clinical Validity of the Meal Rounds Observation Form for Assessing Safe Food Intake in Patients with Dysphagia: A Multicenter Prospective Study. [PDF]
Shimizu M +8 more
europepmc +1 more source
Flavouring Group Evaluation 82 Revision 2 (FGE.82Rev2): Consideration of epoxides evaluated by JECFA. [PDF]
EFSA Panel on Food Additives and Flavourings (FAF) +22 more
europepmc +1 more source
Food-Grade Delivery Systems for Hepatoprotective Functional Foods: From Rational Design and Delivery Mechanisms to Industrial Processing and Nutritional Intervention. [PDF]
Wang J +6 more
europepmc +1 more source

